Jamida of Sweden Tablett Lynx Pink | 27x20 cm

Jamida of Sweden Tablett Lynx Pink | 27x20 cm

Marsoni

M251S

$30.00

Get it in 3 business days with 1 day shipping. Friday, May 29

Jamida of Sweden Tablett Lynx Pink | 27x20 cmDas mrchenhaft wirkende Tablett Lynx der schwedischen Brand Jamida of Sweden sieht nicht nur toll aus, sondern hat auch noch fantastische innere Werte: es ist aus zertifiziertem Birkenholz und von Hand auf der wunderschnen schwedischen Insel land gefertigt.

Easy Shipping

Quick Dispatch:

Your Jamida of Sweden Tablett Lynx Pink | 27x20 cm orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Jamida of Sweden Tablett Lynx Pink | 27x20 cm ships.

Need Help?
Questions about Jamida of Sweden Tablett Lynx Pink | 27x20 cm, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Jamida of Sweden Tablett Lynx Pink | 27x20 cm in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

The shoes came with the correct size and is a good fit. They were originally pretty stiff, but are much better now after breaking them in. They look good. but as other's have said, they are made of synthetic leather and in my opinion have kind of a plastic look to them. The quality is good with ridged rubbber soles. I thought they were kind of expensive, but then again I haven't purchased these type of shoes in a while. A family member told me that if they were real leather, they would have been a lot more expensive. For what the shoes are I would recommend the purchase.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on February 11, 2025